Examiner -- The asthma drug Xolair has been rejected by the National Institute for Health and Clinical Excellence (NICE) for use by children under 12 years of age. This research was done for the UK and recommended to it's National Health Service. Some doctors are concerned that the elimination of this drug will cause children with severe asthma to suffer.
